Prolia and Macrobid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prolia (denosumab) and Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Prolia and Macrobid. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,389 Prolia users. Check the latest studies of Prolia.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

64 people who take Prolia and Macrobid together, and have interactions are studied.

Prolia and Macrobid drug interactions.

What are the common drug interactions of Prolia and Macrobid, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Fungal infection
  4. Injection site pain
  5. Myalgia (muscle pain)
  6. Sinusitis (inflammation of sinus)
  7. White blood cell count decreased
  8. Haemorrhage (bleeding)
  9. Abdominal distension
  10. Infusion site extravasation (flow of (blood or lymph) from infusion site)

male:

n/a

What are the common drug interactions of Prolia and Macrobid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Femur fracture

40-49:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Fall
  4. Headache (pain in head)
  5. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  6. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  7. Nausea (feeling of having an urge to vomit)
  8. Pain in jaw
  9. Post procedural complication
  10. Tinnitus (a ringing in the ears)

50-59:

  1. Abdominal pain
  2. Adverse drug reaction
  3. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Hot flush (sudden feelings of heat)
  7. Throat irritation
  8. Atrophic vulvovaginitis (inflammation of the vulva)
  9. Bone density decreased
  10. Haemorrhoids (a swollen vein or group of veins in the region of the anus)

60+:

  1. Fatigue (feeling of tiredness)
  2. Arthralgia (joint pain)
  3. Abdominal distension
  4. Blood pressure increased
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Cough
  7. Fungal infection
  8. Headache (pain in head)
  9. Alopecia (absence of hair from areas of the body)
  10. Ear infection

What are the existing conditions these people have? *

  1. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 17 people, 26.56%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 10.94%
  3. Immunodeficiency Common Variable: 7 people, 10.94%
  4. High Blood Cholesterol: 6 people, 9.38%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 9.38%
  6. Respiratory Tract Infection Viral: 5 people, 7.81%
  7. Respiratory Tract Infection Bacterial: 5 people, 7.81%
  8. Insomnia (sleeplessness): 5 people, 7.81%
  9. Blood Pressure Abnormal: 5 people, 7.81%
  10. Asthma: 5 people, 7.81%

* Approximation only. Some reports may have incomplete information.

Do you take Prolia and Macrobid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prolia and Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on denosumab and nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Prolia and Macrobid, respectively), and Prolia and Macrobid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: